计算免疫学的前沿领域

计算免疫学是免疫学、计算机科学与人工智能交叉融合下飞速发展的学科。依托人工智能、高通量测序与高性能计算技术的突破，科研人员得以以前所未有的精度解析免疫系统的复杂机制，在疾病诊断、疫苗研发、免疫治疗等领域开辟全新研究方向。

一、基于人工智能的免疫治疗效果预测模型

最具发展前景的方向之一是借助人工智能工具预测患者对免疫疗法的应答情况。2025年，西奈山医院蒂施癌症研究所与纪念斯隆凯特琳癌症中心的研究团队推出一款名为Scorpio的人工智能工具，仅通过常规血液检测，即可判断癌症患者对免疫检查点抑制剂的治疗反应。该成果为基因组分析提供了低成本、易普及的替代方案，有望推动个性化免疫治疗普惠更多患者。

与此同时，克利夫兰医学中心与IBM联合研发的人工智能模型，可预测抗原肽段与免疫细胞的相互作用，助力筛选疗效更优的免疫治疗靶点。免疫检查点抑制剂虽革新了肿瘤治疗，但并非对所有患者有效，因此精准预判治疗应答至关重要。

二、表位预测技术的革命性革新

表位预测领域迎来重大突破，代表性工具DiscoTope 3.0实现全面升级。该工具采用反向折叠结构表征与正无标记学习算法，核心优势在于：无论是实验解析蛋白结构，还是AlphaFold预测的蛋白结构，它均能保持优异预测性能，打破了以往必须依赖实测蛋白结构的限制，使高精度B细胞表位预测的适用范围扩大三个数量级。

该工具兼容RCSB蛋白质数据库与AlphaFold数据库，可对超2亿条已收录蛋白开展大规模预测，是疫苗研发、靶向药物设计、诊断试剂开发的核心工具。

三、单细胞多组学数据整合分析

将单细胞多组学数据与已知免疫生物学知识融合，彻底改写了人类对免疫系统运作机制的认知。研究者将单细胞RNA测序与染色质开放状态等多层分子信息联合分析，更精准地推导转录因子活性与信号级联反应动态，不再仅依靠mRNA表达水平片面判断细胞状态。

空间多组学技术进一步拓展研究边界，为解析细胞间互作提供全新手段。各类计算算法可量化细胞群共定位特征，从空间数据中识别免疫细胞交互事件，揭示黏膜修复、母胎免疫耐受等关键生理过程中的免疫调控机制。

四、免疫系统全流程一体化建模

当前前沿方向是构建可完整模拟免疫全过程的人工智能框架。莫纳什大学与南京大学团队联合开发弱监督深度学习框架ImmuScope，将MHC-II抗原呈递、CD4+T细胞表位识别、免疫原性预测整合为统一分析体系。

这套一体化模型不仅能预判抗原是否会被免疫细胞呈递，还可评估其结合特异性、T细胞识别概率及最终免疫原性。模型结合高质量单等位基因数据集与大规模多等位基因数据，通过迭代多实例学习算法，大幅拓宽MHC-II亚型覆盖范围，提升预测准确度。

五、超算赋能免疫学基础研究

高性能超级计算机助力科研人员解析免疫耐受核心机制。研究团队借助Expanse超算模拟发现，PD-1与CD73两种蛋白可协同抑制CD4+T细胞对自身抗原的免疫应答。该计算模拟结果经实验室验证证实：同步阻断这两个靶点能够增强抗肿瘤免疫应答，为肿瘤免疫治疗提供全新思路。

六、个性化疫苗研发

人工智能驱动的个性化疫苗是计算免疫学核心前沿。2025年，我国两款AI设计的mRNA肿瘤个性化疫苗进入临床试验阶段：君实生物旗下依生生物研发的EVM16、新合生物的XH001。两款疫苗均依托自研AI算法，根据每位患者独有的肿瘤突变，筛选高免疫原性新生抗原。

EVM16已在北京大学肿瘤医院完成首例患者给药，采用脂质纳米颗粒递送系统，特异性激活靶向新生抗原的T细胞；XH001搭载自研AI平台ALPINE，结合患者肿瘤突变图谱与人类白细胞抗原分型定制疫苗，依靠长效免疫记忆降低肿瘤复发风险。这些成果标志着"一人一苗"的肿瘤个性化治疗时代正式到来。

七、免疫受体测序用于疾病诊断

2025年《科学》期刊发表Mal-ID分析框架，证实免疫受体测序在疾病诊断领域的巨大潜力。该工具融合多种机器学习模型，分析B细胞、T细胞受体序列，可同步精准识别多种疾病。

研究团队以新冠、艾滋病、系统性红斑狼疮、1型糖尿病及流感疫苗接种人群为测试样本，该多分类诊断模型曲线下面积高达0.986。框架整合V(D)J基因使用特征、CDR3序列聚类、蛋白质语言模型嵌入特征，捕捉各类疾病专属免疫特征，兼具临床诊断价值与基础生物学研究意义。

八、伦理规范挑战

随着计算免疫学技术快速迭代，生物数据隐私、算法偏差、模型透明度等伦理问题愈发突出。该领域需在人工智能技术红利与敏感生物数据保护间寻求平衡，通过加密存储、分级权限管控保障数据安全。

知情告知流程需清晰说明免疫测序数据的使用范围；科研人员需持续修正训练数据中存在的偏差，避免诊断、治疗方案出现医疗不公。保持算法公开透明、规范生物数据管理，是计算免疫学持续良性发展的基础。

结语

计算免疫学的全新前沿，核心是融合人工智能、高通量测序与高性能计算，系统性破解免疫系统复杂机制。从个性化疫苗设计到单细胞多组学免疫图谱解析，系列技术突破正重塑疾病诊断与治疗模式，深化人类对免疫调控的理解。未来，在技术创新的同时严守伦理规范，才能充分释放计算免疫学在守护人类健康方面的全部潜力。

术语注释（便于阅读）

1. Computational immunology：计算免疫学

2. Epitope：表位（抗原决定簇）

3. Neoantigen：新生抗原

4. MHC：主要组织相容性复合体

5. TCR/BCR：T细胞受体/B细胞受体

6. Immune checkpoint inhibitors：免疫检查点抑制剂

7. Single-cell multi-omics：单细胞多组学

8. mRNA personalized tumor vaccines：mRNA个性化肿瘤疫苗

附：全文英译：

Computational immunology is rapidly advancing at the intersection of immunology, computer science, and artificial intelligence. Here are the key new frontiers shaping this dynamic field.

The New Frontiers of Computational Immunology

Computational immunology is undergoing a transformative phase, driven by advances in artificial intelligence, high-throughput sequencing, and high-performance computing. These technologies are enabling researchers to unravel the complexities of the immune system with unprecedented precision, opening new frontiers in disease diagnosis, vaccine development, and immunotherapy.

AI-Driven Predictive Models for Immunotherapy

One of the most promising areas is the development of AI tools to predict patient responses to immunotherapies. In 2025, researchers from the Tisch Cancer Institute at Mount Sinai and Memorial Sloan Kettering Cancer Center introduced Scorpio, an AI tool that uses routine blood tests to determine cancer patients' responses to immune checkpoint inhibitors (ICIs). This breakthrough offers a scalable, affordable alternative to genomic data analysis, potentially democratizing access to personalized immunotherapy.

Similarly, researchers at Cleveland Clinic and IBMg with IBM have developed AI models that predict how antigen peptides interact with immune cells, aiding in the identification of more effective immunotherapy targets. These advances are particularly significant given that ICIs, while revolutionary for some patients, do not benefit everyone, making accurate response prediction critical.

Revolutionary Approaches to Epitope Prediction

Epitope prediction has taken a major leap forward with DiscoTope-3.0, an improved B-cell epitope prediction tool that employs inverse folding structure representations and positive-unlabelled learning strategies. What sets this tool apart is its high performance across both experimentally solved and AlphaFold-predicted structures, alleviating the long-standing dependency on experimentally determined structures and extending the applicability of accurate B-cell epitope prediction by three orders of magnitude.

With interfaces to RCSB and AlphaFoldDB, DiscoTope-3.0 facilitates large-scale prediction across over 200 million cataloged proteins, making it an invaluable resource for vaccine development, therapeutic design, and diagnostic tool creation.

Single-Cell Multi-Omics Integration

The integration of single-cell multi-omics data with established biological knowledge is transforming our understanding of immune system function. Researchers are combining single-cell RNA sequencing with other molecular layers like chromatin accessibility to gain deeper insights into intracellular processes. This approach enables more accurate inference of transcription factor activity and signal cascade dynamics by considering target gene expression rather than just mRNA levels.

Spatial multi-omics technologies are further enhancing this field by providing new avenues to study cell-cell communication events. Computational methods that quantify cell population colocalization and identify interaction events from spatial data are revealing critical immune regulatory processes at tissue interfaces, including mucosal healing and maternal-fetal immune tolerance.

Comprehensive Immune Process Modeling

A groundbreaking development is the creation of AI frameworks that model entire immune processes. ImmuScope, a weakly supervised deep learning framework developed by researchers from Monash University and Nanjing University, integrates MHC-II antigen presentation, CD4+ T cell epitope identification, and immunogenicity prediction into a unified system.

This comprehensive approach allows researchers to not only predict whether an antigen will be presented but also evaluate its binding specificity, likelihood of T cell recognition, and ultimate immunogenicity. By leveraging both high-quality single-allelic data and large-scale multi-allelic data through self-iterative multiple-instance learning, ImmuScope significantly expands MHC-II subtype coverage and prediction accuracy.

Supercomputing for Immunological Discovery

High-performance computing is enabling breakthroughs in understanding immune tolerance mechanisms. Using the Expanse supercomputer, researchers identified how PD-1 and CD73 proteins synergistically suppress CD4+ T cell responses to self-antigens. This finding, which combines computational modeling with laboratory experiments, revealed that blocking these proteins could boost anti-tumor immune responses, offering new strategies for enhancing cancer immunotherapy.

Personalized Vaccine Development

AI-driven personalized vaccines represent a major frontier in computational immunology. In 2025, China approved clinical trials for two AI-developed mRNA personalized tumor vaccines: EVM16 by Everest Medicines and XH001 by XHBio. These vaccines use proprietary AI algorithms to identify neoantigens with high immunogenicity based on each patient's unique tumor mutations.

EVM16, which completed its first patient dosing at Peking University Cancer Hospital, uses a lipid nanoparticle delivery system to activate neoantigen-specific T cells. Similarly, XH001 employs the NeoCura AI ALPINE system to customize vaccines based on patients' tumor mutation profiles and HLA types, aiming to reduce recurrence risk through long-term immune memory. These developments signal the arrival of the "one patient, one vaccine" era in cancer treatment.

Immune Receptor Sequencing for Disease Diagnosis

The Mal-ID framework, published in Science in 2025, demonstrates the diagnostic potential of immune receptor sequencing. By analyzing B cell and T cell receptor (BCR and TCR) sequences using a combination of machine learning models, Mal-ID can simultaneously detect multiple disease states with remarkable accuracy.

In testing across COVID-19, HIV, systemic lupus erythematosus, type 1 diabetes, and recent influenza vaccine recipients, Mal-ID achieved a multi-class AUROC of 0.986. The framework integrates V(D)J gene usage patterns, CDR3 sequence clustering, and protein language model embeddings to capture disease-specific immune signatures, offering both diagnostic power and biological insights.

Ethical Considerations

As computational immunology advances, ethical concerns around data privacy, algorithmic bias, and transparency become increasingly important. The field must balance the benefits of AI-driven approaches with the need to protect sensitive biological data through robust encryption, secure storage, and controlled access.

Informed consent processes must clearly communicate how immune data will be used, while researchers must vigilantly address potential biases in training data that could lead to inequitable diagnostic or therapeutic outcomes. Maintaining public trust through transparent algorithms and responsible data stewardship is essential for the continued progress of computational immunology.

Conclusion

The new frontiers of computational immunology are defined by integrative approaches that combine AI, high-throughput sequencing, and high-performance computing to unravel immune system complexities. From personalized vaccine design to multi-omics immune profiling, these advances are transforming our ability to diagnose and treat disease through a deeper understanding of immune function. As the field progresses, balancing technical innovation with ethical responsibility will be key to realizing its full potential in improving human health.

These frontiers showcase the dynamic growth of computational immunology, merging technology and biology to tackle complex health challenges. If you'd like to explore any specific area in more detail, feel free to ask.